Neurocast.ai Completes FDA Device Registration, Unlocking U.S. Launch of Brain Health Platform
Amsterdam, Netherlands--(Newsfile Corp. - May 19, 2025) - Neurocast.ai, a digital health company transforming brain health monitoring, has officially registered its passive monitoring platform with the U.S. Food and Drug Administration (FDA) under a 510(k)-exempt classification. This milestone enables Neurocast to bring its breakthrough technology to the U.S. market, starting with multiple sclerosis (MS).
2025-05-19 6:02 AM EDT
Neurocast Unveils Neurokeys Platform To Monitor Brain Health Anytime, Anywhere, Effortlessly With Just Your SmartPhone
Boston, Massachusetts--(Newsfile Corp. - October 27, 2022) - A medical device company called Neurocast with offices in Amsterdam, Netherlands, and Cambridge, Massachusetts is taking brain health to heart with the launch of its new platform NeuroKeys. Neurocast's mission is to provide anyone with insights into their brain health, effortlessly, anytime, anywhere, anyhow. The platform can remotely track brain health in an unobtrusive way through technology like smartphones.This revolutionary digital biomarker developed by the team behind Neurokeys is a smartphone...
2022-10-27 10:49 AM EDT